Voya Investment Management LLC Mersana Therapeutics, Inc. Transaction History

Voya Investment Management LLC

$85.7 Billion
Q2 2024

A detailed history of Voya Investment Management LLC transactions in Mersana Therapeutics, Inc. stock. As of the latest transaction made, Voya Investment Management LLC holds 38,588 shares of MRSN stock, worth $71,387. This represents 0.0% of its overall portfolio holdings.

Number of Shares

38,588

Previous 36,527 5.64%

Holding current value

$71,387

Previous $163,000 52.76%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$2.0 - $4.45 $4,122 - $9,171	2,061 Added 5.64%	38,588 $77,000
Q1 2024 May 15, 2024	SELL	$2.16 - $5.94 $20,532 - $56,465	-9,506 Reduced 20.65%	36,527 $163,000
Q4 2023 Feb 14, 2024	BUY	$1.11 - $2.34 $2,666 - $5,620	2,402 Added 5.51%	46,033 $106,000
Q3 2023 Nov 14, 2023	SELL	$1.06 - $3.91 $13,860 - $51,127	-13,076 Reduced 23.06%	43,631 $55,000
Q2 2023 Aug 14, 2023	SELL	$3.08 - $9.55 $1.37 Million - $4.25 Million	-445,452 Reduced 88.71%	56,707 $186,000
Q1 2023 May 15, 2023	BUY	$4.0 - $7.02 $861,060 - $1.51 Million	215,265 Added 75.03%	502,159 $2.06 Million
Q4 2022 Feb 14, 2023	BUY	$5.65 - $7.86 $268,996 - $374,214	47,610 Added 19.9%	286,894 $1.68 Million
Q3 2022 Mar 03, 2023	SELL	$4.63 - $8.0 $220,434 - $380,880	-47,610 Reduced 16.59%	239,284 $1.62 Million
Q3 2022 Nov 14, 2022	BUY	$4.63 - $8.0 $954,298 - $1.65 Million	206,112 Added 621.34%	239,284 $1.62 Million
Q2 2022 Aug 15, 2022	BUY	$2.84 - $5.0 $19,442 - $34,230	6,846 Added 26.0%	33,172 $153,000
Q4 2021 Feb 14, 2022	SELL	$5.48 - $9.86 $613 - $1,104	-112 Reduced 0.42%	26,326 $164,000
Q2 2021 Aug 16, 2021	BUY	$13.28 - $18.07 $46,320 - $63,028	3,488 Added 15.2%	26,438 $359,000
Q1 2021 May 17, 2021	SELL	$15.31 - $26.52 $1,684 - $2,917	-110 Reduced 0.48%	22,950 $371,000
Q4 2020 Feb 16, 2021	BUY	$16.84 - $27.59 $86,237 - $141,288	5,121 Added 28.55%	23,060 $614,000
Q3 2020 Nov 16, 2020	BUY	$16.2 - $25.7 $32,772 - $51,991	2,023 Added 12.71%	17,939 $334,000
Q2 2020 Aug 14, 2020	SELL	$5.24 - $23.4 $15,987 - $71,393	-3,051 Reduced 16.09%	15,916 $372,000
Q4 2019 Feb 14, 2020	BUY	$1.45 - $6.73 $8,552 - $39,693	5,898 Added 45.13%	18,967 $109,000
Q2 2019 Aug 14, 2019	BUY	$3.84 - $6.4 $50,184 - $83,641	13,069 New	13,069 $53,000

Others Institutions Holding MRSN

# of Institutions

124

Shares Held

114M

Call Options Held

73.5K

Put Options Held

46.4K

View Full List

About Mersana Therapeutics, Inc.

Ticker MRSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,169,296
Market Cap $180M
Description
Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...

More about MRSN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.

Account

Voya Investment Management LLC Mersana Therapeutics, Inc. Transaction History